title: Assessment of insulin resistance and impaired glucose tolerance in lean women with polycystic ovary syndrome.
abstract: OBJECTIVE
  To analyze insulin resistance (IR) and determine the need for a 2-hour oral glucose tolerance test (OGTT) for the identification of IR and impaired glucose tolerance (IGT) in lean nondiabetic women with polycystic ovary syndrome (PCOS).
  
  
  METHODS
  This was a cross-sectional analysis of treatment-naive women with PCOS who enrolled in a university-based clinical trial. Nondiabetic women with PCOS based on the Eunice Kennedy Shriven National Institute of Child Health and Human Development (NICHD) definition, aged 18-43 years and weighing ≤113 kg, were evaluated. Glucose and insulin levels were assessed at times 0, 30, 60, 90, and 120 minutes after a 75-g glucose load. Lean was defined as body mass index (BMI) <25 kg/m(2). Multiple linear regression was performed.
  
  
  RESULTS
  A cohort of 78 women was studied. The prevalence of IR was 0% among lean women vs. 21% among nonlean subjects based on fasting insulin I(0) and 40%-68% based on two different homeostatic model assessment (HOMA) cutoff points (p < 0.005). All women with IR had a BMI ≥ 28. Controlling for age and race, BMI explained over 57% of the variation in insulin fasting (I(o)), glucose fasting/Io (G(o)/I(o)), the qualitative insulin sensitivity check index (QUICKI), and HOMA and was a highly significant predictor of these outcomes (p < 0.0001). Only 1 of 31 (3%) of the lean PCOS women had IGT based on a 2-hour OGTT, and no lean subjects had IGT based on their fasting blood glucose.
  
  
  CONCLUSIONS
  Diabetes mellitus, IGT, and IR are far less common in young lean women with PCOS compared with obese women with PCOS. These data imply that it is unnecessary to routinely perform either IR testing or 2-hour OGTT in lean women with PCOS; however, greater subject accumulation is needed to determine if OGTT is necessary in lean women with PCOS. BMI is highly predictive of both insulin and glucose levels in women with PCOS.
authors.affiliation: Department of Obstetrics and Gynecology, The University of Virginia, Charlottesville, VA 22908-0712, USA. ds2as@virginia.edu
authors.forename: Dale William
authors.initials: DW
authors.lastname: Stovall
authors.forename: Amelia Purser
authors.initials: AP
authors.lastname: Bailey
authors.forename: Lisa M
authors.initials: LM
authors.lastname: Pastore
mesh_terms: D000293:Adolescent; D000328:Adult; D001786:Blood Glucose / Q000502:physiology; D015992:Body Mass Index; D015331:Cohort Studies; D003430:Cross-Sectional Studies; D005215:Fasting / Q000097:blood; D005260:Female; D018149:Glucose Intolerance / Q000150:complications* / Q000453:epidemiology / Q000209:etiology; D005951:Glucose Tolerance Test / Q000706:statistics & numerical data; D006442:Glycated Hemoglobin / Q000032:analysis; D006706:Homeostasis / Q000502:physiology; D006801:Humans; D007328:Insulin / Q000097:blood / Q000502:physiology; D007333:Insulin Resistance; D011085:Polycystic Ovary Syndrome / Q000150:complications / Q000175:diagnosis* / Q000453:epidemiology / Q000209:etiology; D015995:Prevalence; D012680:Sensitivity and Specificity; D013739:Testosterone / Q000097:blood; D013851:Thinness / Q000503:physiopathology; D016387:Women's Health
chemical_list: D001786:Blood Glucose; D006442:Glycated Hemoglobin; D007328:Insulin; D013739:Testosterone